PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Thomas Hamilton to Speak About the Cytokine Regulation at Cytokines Conference on January 29-31, 2014 in San Diego, California - Thomas Hamilton will present about “Regulation of TLR-Induced Cytokine Expression by Environmental Stress” at the 12th Cytokines & Inflammation Conference, to be held January 29-31, 2014 in San Diego, CA
Thomas Hamilton to Speak About the Cytokine Regulation at Cytokines Conference on January 29-31, 2014 in San Diego, California

 

NewswireToday - /newswire/ - Monrovia, CA, United States, 2013/10/07 - Thomas Hamilton will present about “Regulation of TLR-Induced Cytokine Expression by Environmental Stress” at the 12th Cytokines & Inflammation Conference, to be held January 29-31, 2014 in San Diego, CA.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Dr. Hamilton currently serves as the Chairman of the Department of Immunology at the Lerner Research Institute of the Cleveland Clinic Foundation, where his research focuses on studying the regulation of inflammatory cytokine and chemokine gene expression. His laboratory has made substantial contributions to the understanding of both transcriptional and post-transcriptional control mechanisms regulating innate inflammatory responses in myeloid and non-myeloid cell populations.

He will discuss how cellular stress can amplify the expression of selected inflammatory cytokines in myeloid cell populations. For example, TLR-stimulated CXCL1 and CXCL2 chemokine mRNA levels are enhanced more than ten-fold in stressed macrophages, while mRNAs encoding CCL5 and CXCL10 are not. Other pro-inflammatory cytokines that show elevated levels of stress include TNFa, IL-1a, and IL-6.

Stress responses also enhance chemokine protein levels during peritoneal inflammation. TLR4 is the most sensitive, though other TLR responses are also enhanced. Stress-enhanced chemokine gene expression is mediated by altered transcription, but NFkB activation, though necessary, does not appear to be the target of stress.

Similarly, while the IRF3 transcription factor is linked to TLR4 signaling, IRF3 is not required for stress sensitivity. Though mediators of endoplasmic reticulum stress (IRE-1, XBP-1, and CHOP) have been implicated in altered inflammatory cytokine responses, they are not required for amplification of TLR4-induced chemokine expression. Rather, RIP1, a kinase that participates in TLR3 andTLR4/TRIF signaling, is required through a pathway that involves stress-dependent increases in RIP1 protein levels and activation via ubiquitinylation.

Dr. Hamilton will discuss how these findings, which identify novel mechanisms for modulating the magnitude and duration of selective TLR-induced chemokine and cytokine gene expression, further establish the importance of environmental stress in coordinating the outcomes of cellular and tissue injury.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: GTCbio - Biopharmaceutical Conference

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Thomas Hamilton to Speak About the Cytokine Regulation at Cytokines Conference on January 29-31, 2014 in San Diego, California

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: GTCbio.com 
626-256-6405 infogtcbio[.]gtcbio.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any GTCbio - Biopharmaceutical Conference securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From GTCbio - Biopharmaceutical Conference / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

PleurX™ Catheter System Receives FDA 510(k) Clearance for Specific Non-Malignant Recurrent Pleural Effusions
First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics
Sartorius Announces Expansion of Sartorius Stedim Cellca
Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)